| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |